Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Fast Track Articles
  5. Fast Track Article
image of Advanced Pain Management in Patients with Terminal Cancer

Abstract

Understanding and managing pain in patients with terminal cancer is a vital aspect of palliative care, aimed at relieving suffering and improving quality of life in the final stages of illness. Studies indicate that approximately 50% of patients with stage 4 cancer report moderate to severe pain, with a quarter experiencing severe cancer-related pain. Despite opioid prescriptions in 97% of cases, a significant portion of patients continues to suffer unresolved pain during the last week of life. Cancer-related pain is multifaceted, often involving nociceptive, neuropathic, and mixed elements, necessitating a thorough, multidimensional approach to both assessment and treatment. The challenge of opioid tolerance and the potential for addiction demands careful monitoring. Interventional therapies, including nerve blocks and spinal cord stimulation, are gaining attention as valuable complements or alternatives to opioid use. Additionally, alternative methods like yoga, special diets, and food supplements provide diverse options for managing pain. Psychological therapies, including cognitive-behavioral techniques and mindfulness, address the mental and emotional dimensions of pain. Emerging technologies, including artificial intelligence, hold promise for optimizing pain management in terminal cancer care. This review explores advanced pain management strategies, focusing on traditional opioid therapies, modern pharmaceutical innovations, and non-pharmacological approaches such as alternative medicine, massage, dietary interventions, and psychological therapy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673333227250106085952
2024-01-24
2025-04-22

  • From This Site

    /content/journals/cmc/10.2174/0109298673333227250106085952
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Cancer of any site: Cancer stat facts 2023 seer.cancer.gov/statfacts/html/all.html
  2. Ferlay J. Colombet M. Soerjomataram I. Parkin D.M. Piñeros M. Znaor A. Bray F. Cancer statistics for the year 2020: An overview. Int. J. Cancer 2021 149 4 778 789 10.1002/ijc.33588 33818764
    [Google Scholar]
  3. Mestdagh F. Steyaert A. Lavand’homme P. Cancer pain management: A narrative review of current concepts, strategies, and techniques. Curr. Oncol. 2023 30 7 6838 6858 10.3390/curroncol30070500 37504360
    [Google Scholar]
  4. Snijders R. Brom L. Theunissen M. van den Beuken-van Everdingen M. Update on prevalence of pain in patients with cancer 2022: A systematic literature review and meta-analysis. Cancers (Basel) 2023 15 3 591 10.3390/cancers15030591 36765547
    [Google Scholar]
  5. Pogodina V.V. Elizaveta Nilolaevna Levkovich-75th birthday. Acta Virol. 1975 19 6 509 2002
    [Google Scholar]
  6. Breivik H. Cherny N. Collett B. de Conno F. Filbet M. Foubert A.J. Cohen R. Dow L. Cancer-related pain: A pan-European survey of prevalence, treatment, and patient attitudes. Ann. Oncol. 2009 20 8 1420 1433 10.1093/annonc/mdp001 19244085
    [Google Scholar]
  7. Evenepoel M. Haenen V. De Baerdemaecker T. Meeus M. Devoogdt N. Dams L. Van Dijck S. Van der Gucht E. De Groef A. Pain prevalence during cancer treatment: A systematic review and meta-analysis. J. Pain Symptom Manage. 2022 63 3 e317 e335 10.1016/j.jpainsymman.2021.09.011 34563628
    [Google Scholar]
  8. Barrell K. Smith A.G. Peripheral neuropathy. Med. Clin. North Am. 2019 103 2 383 397 10.1016/j.mcna.2018.10.006 30704689
    [Google Scholar]
  9. Stubblefield M. D. Burstein H.J. Burton A. W. Custodio C. M. Deng G. E. Ho M. Junck L. Morris G. S. Paice J.A. Tummala S. NCCN task force report: Management of neuropathy in cancer J Natl Compr Canc Netw. 2009 7 5 S1 S26 10.6004/jnccn.2009.0078
    [Google Scholar]
  10. Pike C.T. Birnbaum H.G. Muehlenbein C.E. Pohl G.M. Natale R.B. Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother. Res. Pract. 2012 2012 1 10 10.1155/2012/913848 22482054
    [Google Scholar]
  11. Klint Å. Bondesson E. Rasmussen B.H. Fürst C.J. Schelin M.E.C. Dying with unrelieved pain—prescription of opioids is not enough. J. Pain Symptom Manage. 2019 58 5 784 791.e1 10.1016/j.jpainsymman.2019.07.006 31319106
    [Google Scholar]
  12. Carrasco J.M. Inbadas H. Whitelaw A. Clark D. Early impact of the 2014 world health assembly resolution on palliative care: A qualitative study using semistructured interviews with key experts. J. Palliat. Med. 2021 24 1 103 106 10.1089/jpm.2019.0384 32191149
    [Google Scholar]
  13. Temel J.S. Greer J.A. Muzikansky A. Gallagher E.R. Admane S. Jackson V.A. Dahlin C.M. Blinderman C.D. Jacobsen J. Pirl W.F. Billings J.A. Lynch T.J. Early palliative care for patients with metastatic non-small-cell lung cancer. N. Engl. J. Med. 2010 363 8 733 742 10.1056/NEJMoa1000678 20818875
    [Google Scholar]
  14. Zimmermann C. Swami N. Krzyzanowska M. Hannon B. Leighl N. Oza A. Moore M. Rydall A. Rodin G. Tannock I. Donner A. Lo C. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial. Lancet 2014 383 9930 1721 1730 10.1016/S0140‑6736(13)62416‑2 24559581
    [Google Scholar]
  15. Dying in America: Improving quality and honoring individual preferences near the end of life. Washington, D.C. National Academies Press 2015 18748 10.17226/18748
    [Google Scholar]
  16. World Health Organization World Health Organization Model List of Essential Medicines – 23rd List, 2023: Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines World Health Organization Geneva, Switzerland 2023
    [Google Scholar]
  17. Knaul F.M. Farmer P.E. Krakauer E.L. De Lima L. Bhadelia A. Jiang Kwete X. Arreola-Ornelas H. Gómez-Dantés O. Rodriguez N.M. Alleyne G.A.O. Connor S.R. Hunter D.J. Lohman D. Radbruch L. del Rocío Sáenz Madrigal M. Atun R. Foley K.M. Frenk J. Jamison D.T. Rajagopal M.R. Knaul F.M. Farmer P.E. Abu-Saad Huijer H. Alleyne G.A.O. Atun R. Binagwaho A. Bošnjak S.M. Clark D. Cleary J.F. Cossío Díaz J.R. De Lima L. Foley K.M. Frenk J. Goh C. Goldschmidt-Clermont P.J. Gospodarowicz M. Gwyther L. Higginson I.J. Hughes-Hallett T. Hunter D.J. Jamison D.T. Krakauer E.L. Lohman D. Luyirika E.B.K. Medina Mora M.E. Mwangi-Powell F.N. Nishtar S. O’Brien M.E. Radbruch L. Rajagopal M.R. Reddy K.S. del Rocío Sáenz Madrigal M. Salerno J.A. Bhadelia A. Allende S. Arreola-Ornelas H. Bhadelia N. Calderon M. Connor S.R. Fan V.Y. Gómez-Dantés O. Jiménez J. Ntizimira C.R. Perez-Cruz P.E. Salas-Herrera I.G. Spence D. Steedman M.R. Verguet S. Downing J.D. Paudel B.D. Elsner M. Gillespie J.A. Hofman K.J. Jiang Kwete X. Khanh Q.T. Lorenz K.A. Méndez Carniado O. Nugent R. Rodriguez N.M. Wroe E.B. Zimmerman C. Lancet Commission on Palliative Care and Pain Relief Study Group Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: The lancet commission report. Lancet 2018 391 10128 1391 1454 10.1016/S0140‑6736(17)32513‑8 29032993
    [Google Scholar]
  18. Chang V.T. Janjan N. Jain S. Chau C. Update in cancer pain syndromes. J. Palliat. Med. 2006 9 6 1414 1434 10.1089/jpm.2006.9.1414 17187550
    [Google Scholar]
  19. Urch C.E. Dickenson A.H. Neuropathic pain in cancer. Eur. J. Cancer 2008 44 8 1091 1096 10.1016/j.ejca.2008.03.015 18492553
    [Google Scholar]
  20. Caraceni A. Portenoy R.K. a working group of the IASP Task Force on Cancer Pain International Association for the Study of Pain An international survey of cancer pain characteristics and syndromes. Pain 1999 82 3 263 274 10.1016/S0304‑3959(99)00073‑1 10488677
    [Google Scholar]
  21. Nicholson B. Differential diagnosis: Nociceptive and neuropathic pain. Am. J. Manag. Care 2006 12 9 Suppl. S256 S262 16774457
    [Google Scholar]
  22. Yoon S.Y. Oh J. Neuropathic cancer pain: Prevalence, pathophysiology, and management. Korean J. Intern. Med. (Korean. Assoc. Intern. Med.) 2018 33 6 1058 1069 10.3904/kjim.2018.162 29929349
    [Google Scholar]
  23. Poço Gonçalves J. Veiga D. Araújo A. Chronic pain, functionality and quality of life in cancer survivors. Br. J. Pain 2021 15 4 401 410 10.1177/2049463720972730 34840788
    [Google Scholar]
  24. Bennett M.I. Rayment C. Hjermstad M. Aass N. Caraceni A. Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain 2012 153 2 359 365 10.1016/j.pain.2011.10.028 22115921
    [Google Scholar]
  25. Jensen M.P. Karoly P. Measurement of cancer pain via patient self-report. Current and Emerging Issues in Cancer Pain: Research and Practice. Raven Press New York 1993
    [Google Scholar]
  26. Weinstein S.M. Romanus D. Lepisto E.M. Reyes-Gibby C. Cleeland C. Greene R. Muir C. Niland J. Documentation of pain in comprehensive cancer centers in the United States: A preliminary analysis. J. Natl. Compr. Canc. Netw. 2004 2 2 173 180 10.6004/jnccn.2004.0015 19777706
    [Google Scholar]
  27. McPherson C.J. Hadjistavropoulos T. Lobchuk M.M. Kilgour K.N. Cancer-related pain in older adults receiving palliative care: Patient and family caregiver perspectives on the experience of pain. Pain Res. Manag. 2013 18 6 293 300 10.1155/2013/439594 23957019
    [Google Scholar]
  28. Bruera E. MacMillan K. Hanson J. MacDonald R.N. The Edmonton staging system for cancer pain: Preliminary report. Pain 1989 37 2 203 209 10.1016/0304‑3959(89)90131‑0 2748193
    [Google Scholar]
  29. Bruera E. Moyano J. Seifert L. Fainsinger R.L. Hanson J. Suarez-Almazor M. The frequency of alcoholism among patients with pain due to terminal cancer. J. Pain Symptom Manage. 1995 10 8 599 603 10.1016/0885‑3924(95)00084‑4 8594120
    [Google Scholar]
  30. Belayneh M. Fainsinger R. Nekolaichuk C. Muller V. Bouchard S. Downar J. Galloway L. Ghosh S. Hawley P. Herx L. Kmet A. Lawlor P. Edmonton classification system for cancer pain: Comparison of pain classification features and pain intensity across diverse palliative care settings in Canada. J. Palliat. Med. 2023 26 3 366 375 10.1089/jpm.2022.0187 36282783
    [Google Scholar]
  31. Von Korff M. Ormel J. Keefe F.J. Dworkin S.F. Grading the severity of chronic pain. Pain 1992 50 2 133 149 10.1016/0304‑3959(92)90154‑4 1408309
    [Google Scholar]
  32. Melzack R. The McGill pain questionnaire: Major properties and scoring methods. Pain 1975 1 3 277 299 10.1016/0304‑3959(75)90044‑5 1235985
    [Google Scholar]
  33. Anekar A.A. Hendrix J.M. Cascella M. WHO Analgesic Ladder Treasure Island, FL StatPearls Publishing 2024
    [Google Scholar]
  34. Ventafridda V. Saita L. Ripamonti C. De Conno F. WHO guidelines for the use of analgesics in cancer pain. Int. J. Tissue React. 1985 7 1 93 96 2409039
    [Google Scholar]
  35. Simmons D.L. Botting R.M. Hla T. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 2004 56 3 387 437 10.1124/pr.56.3.3 15317910
    [Google Scholar]
  36. Derry S. Wiffen P.J. Moore R.A. McNicol E.D. Bell R.F. Carr D.B. McIntyre M. Wee B. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst. Rev. 2017 7 7 CD012638 10.1002/14651858.CD012638.pub2 28700091
    [Google Scholar]
  37. Harirforoosh S. Asghar W. Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. J. Pharm. Pharm. Sci. 2014 16 5 821 847 10.18433/J3VW2F 24393558
    [Google Scholar]
  38. Mallet C. Desmeules J. Pegahi R. Eschalier A. An updated review on the metabolite (AM404)-Mediated central mechanism of action of paracetamol (Acetaminophen): Experimental evidence and potential clinical impact J Pain Res 2023 16 1081 1094 10.2147/JPR.S393809
    [Google Scholar]
  39. Hawton K. Townsend E. Deeks J. Appleby L. Gunnell D. Bennewith O. Cooper J. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: Before and after study. BMJ 2001 322 7296 1203 1207 10.1136/bmj.322.7296.1203 11358770
    [Google Scholar]
  40. Norris W. Paredes A.H. Lewis J.H. Drug-induced liver injury in 2007. Curr. Opin. Gastroenterol. 2008 24 3 287 297 10.1097/MOG.0b013e3282f9764b 18408456
    [Google Scholar]
  41. Myers J. Shetty N. Going beyond efficacy: Strategies for cancer pain management Curr Oncol 2008 15 1 S41 10.3747/co.2008.175
    [Google Scholar]
  42. Strong opioids for osteoarthritis in primary care? Drug Ther. Bull. 2009 47 12 138 141 10.1136/dtb.2009.11.0053 20009041
    [Google Scholar]
  43. Wickham R.J. Cancer pain management: Opioid analgesics, Part 2. J. Adv. Pract. Oncol. 2017 8 6 588 607 30310721
    [Google Scholar]
  44. US Food and Drug Administration Safety measures announced for extended-release and long-acting opioids. fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm363722.htm
  45. Trescot A.M. Datta S. Lee M. Hansen H. Opioid pharmacology. Pain Physician 2008 2s 11 Suppl. S133 S153 10.36076/ppj.2008/11/S133 18443637
    [Google Scholar]
  46. Kurita G. Sjøgren P. Klepstad P. Mercadante S. Interventional techniques for the management of cancer-related pain: Clinical and critical aspects. Cancers 2019 11 4 443 10.3390/cancers11040443 30934870
    [Google Scholar]
  47. Bottros M.M. Christo P.J. Current perspectives on intrathecal drug delivery. J. Pain Res. 2014 7 Nov 615 626 10.2147/JPR.S37591 25395870
    [Google Scholar]
  48. Deer T.R. Mekhail N. Provenzano D. Pope J. Krames E. Leong M. Levy R.M. Abejon D. Buchser E. Burton A. Buvanendran A. Candido K. Caraway D. Cousins M. DeJongste M. Diwan S. Eldabe S. Gatzinsky K. Foreman R.D. Hayek S. Kim P. Kinfe T. Kloth D. Kumar K. Rizvi S. Lad S.P. Liem L. Linderoth B. Mackey S. McDowell G. McRoberts P. Poree L. Prager J. Raso L. Rauck R. Russo M. Simpson B. Slavin K. Staats P. Stanton-Hicks M. Verrills P. Wellington J. Williams K. North R. Neuromodulation Appropriateness Consensus Committee The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: The Neuromodulation Appropriateness Consensus Committee. Neuromodulation 2014 17 6 515 550 10.1111/ner.12208 25112889
    [Google Scholar]
  49. Kerr L.M. Filloux F. Olivera B.M. Jackson H. Wamsley J.K. Autoradiographic localization of calcium channels with [125I]ω-conotoxin in rat brain. Eur. J. Pharmacol. 1988 146 1 181 183 10.1016/0014‑2999(88)90501‑8 2450766
    [Google Scholar]
  50. Westenbroek R.E. Hoskins L. Catterall W.A. Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J. Neurosci. 1998 18 16 6319 6330 10.1523/JNEUROSCI.18‑16‑06319.1998 9698323
    [Google Scholar]
  51. Upadhyay S.P. Mallick P.N. Intrathecal drug delivery system (IDDS) for cancer pain management: A review and updates. Am. J. Hosp. Palliat. Care 2012 29 5 388 398 10.1177/1049909111426134 22089523
    [Google Scholar]
  52. Hao D. Sidharthan S. Cotte J. Decker M. Salisu-Orhurhu M. Olatoye D. Karri J. Hagedorn J.M. Adekoya P. Odonkor C. Gulati A. Orhurhu V. Interventional therapies for pain in cancer patients: A narrative review. Curr. Pain Headache Rep. 2021 25 7 44 10.1007/s11916‑021‑00963‑2 33961156
    [Google Scholar]
  53. Berry J.A. Elia C. Saini H.S. Miulli D.E. A review of lumbar radiculopathy, diagnosis, and treatment. Cureus 2019 11 10 e5934 10.7759/cureus.5934 31788391
    [Google Scholar]
  54. Woods B.I. Hilibrand A.S. Cervical radiculopathy. J. Spinal Disord. Tech. 2015 28 5 E251 E259 10.1097/BSD.0000000000000284 25985461
    [Google Scholar]
  55. Cicala R.S. Thoni K. Angel J.J. Long-term results of cervical epidural steroid injections. Clin. J. Pain 1989 5 2 143 146 10.1097/00002508‑198906000‑00003 2520395
    [Google Scholar]
  56. Manchikanti L. Buenaventura R.M. Manchikanti K.N. Ruan X. Gupta S. Smith H.S. Christo P.J. Ward S.P. Effectiveness of therapeutic lumbar transforaminal epidural steroid injections in managing lumbar spinal pain. Pain Physician 2012 3 15 E199 E245 10.36076/ppj.2012/15/E199 22622912
    [Google Scholar]
  57. Oh D.C. Rispoli L. Ghosh P. Gulati A. Epidural steroid injections for the management of spinal malignancy‐related pain: A pragmatic review and retrospective study. Pain Pract. 2021 21 3 285 298 10.1111/papr.12957 33025670
    [Google Scholar]
  58. Simone C.B. II Vapiwala N. Hampshire M.K. Metz J.M. Cancer patient attitudes toward analgesic usage and pain intervention. Clin. J. Pain 2012 28 2 157 162 10.1097/AJP.0b013e318223be30 21705874
    [Google Scholar]
  59. Thinh D.H.Q. Sriraj W. Mansor M. Tan K.H. Irawan C. Kurnianda J. Nguyen Y.P. Ong-Cornel A. Hadjiat Y. Moon H. Javier F.O. Analgesic prescription patterns and pain outcomes in Southeast Asia: Findings from the analgesic treatment of cancer pain in Southeast Asia study. J. Glob. Oncol. 2018 4 4 1 10 10.1200/JGO.17.00055 30241271
    [Google Scholar]
  60. Vallersnes O.M. Jacobsen D. Ekeberg Ø. Brekke M. Mortality, morbidity and follow-up after acute poisoning by substances of abuse: A prospective observational cohort study. Scand. J. Public Health 2019 47 4 452 461 10.1177/1403494818779955 29886813
    [Google Scholar]
  61. Kosten T. George T. The neurobiology of opioid dependence: Implications for treatment. Sci. Pract. Perspect. 2002 1 1 13 20 10.1151/spp021113 18567959
    [Google Scholar]
  62. Berridge C.W. Waterhouse B.D. The locus coeruleus–noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003 42 1 33 84 10.1016/S0165‑0173(03)00143‑7 12668290
    [Google Scholar]
  63. Page R. Blanchard E. Opioids and cancer pain: Patients’ needs and access challenges. J. Oncol. Pract. 2019 15 5 229 231 10.1200/JOP.19.00081 31013181
    [Google Scholar]
  64. Paolozzi L.J. Jones C.M. Mack K.A. Rudd R.A. Vital Signs: Overdoses of prescription opioid pain relievers: United States. CDC 1999 60 43 1487 1492
    [Google Scholar]
  65. Rudd R.A. Paulozzi L.J. Bauer M.J. Burleson R.W. Carlson R.E. Dao D. Davis J.W. Dudek J. Eichler B.A. Fernandes J.C. Fondario A. Gabella B. Hume B. Huntamer T. Kariisa M. Largo T.W. Miles J. Newmyer A. Nitcheva D. Perez B.E. Proescholdbell S.K. Sabel J.C. Skiba J. Slavova S. Stone K. Tharp J.M. Wendling T. Wright D. Zehner A.M. Centers for Disease Control and Prevention (CDC) Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR Morb. Mortal. Wkly. Rep. 2014 63 39 849 854 25275328
    [Google Scholar]
  66. O’Donnell J.K. Gladden R.M. Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region — United States, 2006–2015. MMWR Morb. Mortal. Wkly. Rep. 2017 66 34 897 903 10.15585/mmwr.mm6634a2 28859052
    [Google Scholar]
  67. Hwang J. Shen J.J. Kim S.J. Chun S.Y. Kim P.C. Lee S.W. Byun D. Yoo J.W. Opioid use disorders and hospital palliative care among patients with gastrointestinal cancers. Medicine (Baltimore) 2020 99 25 e20723 10.1097/MD.0000000000020723 32569209
    [Google Scholar]
  68. Volkow N.D. Jones E.B. Einstein E.B. Wargo E.M. Prevention and treatment of opioid misuse and addiction. JAMA Psychiatry 2019 76 2 208 216 10.1001/jamapsychiatry.2018.3126 30516809
    [Google Scholar]
  69. Carmichael A.N. Morgan L. Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review. Subst. Abuse Rehabil. 2016 7 71 79 10.2147/SAR.S85409 27330340
    [Google Scholar]
  70. Jairam V. Yang D.X. Verma V. Yu J.B. Park H.S. National patterns in prescription opioid use and misuse among cancer survivors in the United States. JAMA Netw. Open 2020 3 8 e2013605 10.1001/jamanetworkopen.2020.13605 32804217
    [Google Scholar]
  71. Berger A.M. Von Roenn J.H. Shuster J.L. Principles and practice of Palliative Care and Supportive Oncology, 4e. Lippincott Williams & Wilkins 2013
    [Google Scholar]
  72. Mathews J.L. Smrcka A.V. Bidlack J.M. A novel Gbetagamma-subunit inhibitor selectively modulates μ-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence. J. Neurosci. 2008 28 47 12183 12189 10.1523/JNEUROSCI.2326‑08.2008 19020012
    [Google Scholar]
  73. Song H. Kim M. Kim E. Lee J. Jeong I. Lim K. Ryu S.Y. Oh M. Kim Y. Park J.U. Neuromodulation of the peripheral nervous system: Bioelectronic technology and prospective developments. BMEMat 2024 2 1 e12048 10.1002/bmm2.12048
    [Google Scholar]
  74. Peng L. Min S. Zejun Z. Wei K. Bennett M.I. Spinal cord stimulation for cancer-related pain in adults. Cochrane Libr. 2015 2019 7 CD009389 10.1002/14651858.CD009389.pub3 26121600
    [Google Scholar]
  75. Cata J.P. Cordella J.V. Burton A.W. Hassenbusch S.J. Weng H.R. Dougherty P.M. Spinal cord stimulation relieves chemotherapy-induced pain: A clinical case report. J. Pain Symptom Manage. 2004 27 1 72 78 10.1016/j.jpainsymman.2003.05.007 14711471
    [Google Scholar]
  76. Crowther J.E. Chen G.H. Legler A. Gulati A. Spinal cord stimulation in the treatment of cancer pain: A retrospective review. Neuromodulation 2022 25 5 693 699 10.1016/j.neurom.2022.01.023 35410770
    [Google Scholar]
  77. Hagedorn J. M. Pittelkow T. P. Hunt C. L. D’Souza R. S. Lamer T. J. Current perspectives on spinal cord stimulation for the treatment of cancer pain Neuromodulation 2020 25 693 699 10.2147/JPR.S263857
    [Google Scholar]
  78. Wray J.K. Dixon B. Przkora R. Radiofrequency Ablation StatPearls Treasure Island 2024 29494009
    [Google Scholar]
  79. Markman J.D. Philip A. Interventional approaches to pain management. Anesthesiol. Clin. 2007 25 4 883 898, viii 10.1016/j.anclin.2007.07.012 18054151
    [Google Scholar]
  80. Gallusser N. Goetti P. Becce F. Vauclair F. Rüdiger H.A. Bize P.E. Cherix S. Percutaneous image-guided cryoablation of painful bone metastases: A single institution experience. Orthop. Traumatol. Surg. Res. 2019 105 2 369 374 10.1016/j.otsr.2019.01.001 30858041
    [Google Scholar]
  81. Coupal T.M. Pennycooke K. Mallinson P.I. Ouellette H.A. Clarkson P.W. Hawley P. Munk P.L. The hopeless case? Palliative cryoablation and cementoplasty procedures for palliation of large pelvic bone metastases. Pain Physician 2017 7 20;7 E1053 E1061 10.36076/ppj/2017.7.E1053 29149150
    [Google Scholar]
  82. Cazzato R.L. Garnon J. Caudrelier J. Rao P.P. Koch G. Gangi A. Low-power bipolar radiofrequency ablation and vertebral augmentation for the palliative treatment of spinal malignancies. Int. J. Hyperthermia 2018 34 8 1282 1288 10.1080/02656736.2017.1422557 29347855
    [Google Scholar]
  83. Bogduk N. Dreyfuss P. Baker N. Bogduk R. Yin W. Landers M. Hammer M. Aprill A. Complications of spinal diagnostic and treatment procedures Pain Med. 2008 9 1 S11 S34 10.1111/j.1526‑4637.2008.00437.x
    [Google Scholar]
  84. Rana M.V. Candido K.D. Raja O. Knezevic N.N. Celiac plexus block in the management of chronic abdominal pain. Curr. Pain Headache Rep. 2014 18 2 394 10.1007/s11916‑013‑0394‑z 24414338
    [Google Scholar]
  85. Sindt J.E. Brogan S.E. Interventional treatments of cancer pain. Anesthesiol. Clin. 2016 34 2 317 339 10.1016/j.anclin.2016.01.004 27208713
    [Google Scholar]
  86. Cornman-Homonoff J. Holzwanger D. Lee K. Madoff D. Li D. Celiac Plexus block and neurolysis in the management of chronic upper abdominal pain. Semin. Intervent. Radiol. 2017 34 4 376 386 10.1055/s‑0037‑1608861 29249862
    [Google Scholar]
  87. Eisenberg E. Carr D.B. Chalmers T.C. Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis. Anesth. Analg. 1995 80 2 290 295 10.1097/00000539‑199502000‑00015 7818115
    [Google Scholar]
  88. Fallon M. Giusti R. Aielli F. Hoskin P. Rolke R. Sharma M. Ripamonti C.I. ESMO Guidelines Committee Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann. Oncol. 2018 29 Suppl. 4 iv166 iv191 10.1093/annonc/mdy152 30052758
    [Google Scholar]
  89. Bethesda (MD) Collection Development Guidelines of the National Library of Medicine National Library of Medicine US 2019
    [Google Scholar]
  90. Adams M. Jewell A.P. The use of complementary and alternative medicine by cancer patients. Int. Semin. Surg. Oncol. 2007 4 1 10 10.1186/1477‑7800‑4‑10 17470282
    [Google Scholar]
  91. Zhang Y. Wang S. Ma X. Yuan Y. Cheng H. Lin L. Tian L. Massage therapy can effectively relieve cancer pain: A meta-analysis. Medicine (Baltimore) 2023 102 27 e33939 10.1097/MD.0000000000033939 37417622
    [Google Scholar]
  92. Fortin J. Beaupré A. Thamar Louis L.A. Roy C.A. Bourque M.A. Cappeliez S. Fadhlaoui A. Osteopathy as a complementary/alternative medicine for breast cancer: A Canadian case study and comprehensive review. Breast Cancer Manag. 2022 11 2 BMT63 10.2217/bmt‑2022‑0002
    [Google Scholar]
  93. Deng G. Integrative medicine therapies for pain management in cancer patients. Cancer J. 2019 25 5 343 348 10.1097/PPO.0000000000000399 31567462
    [Google Scholar]
  94. Mercier B.D. Tizpa E. Philip E.J. Feng Q. Huang Z. Thomas R.M. Pal S.K. Dorff T.B. Li Y.R. Dietary interventions in cancer treatment and response: A comprehensive review. Cancers 2022 14 20 5149 10.3390/cancers14205149 36291933
    [Google Scholar]
  95. Yang J. Wahner-Roedler D.L. Zhou X. Johnson L.A. Do A. Pachman D.R. Chon T.Y. Salinas M. Millstine D. Bauer B.A. Acupuncture for palliative cancer pain management: Systematic review. BMJ Support. Palliat. Care 2021 11 3 264 270 10.1136/bmjspcare‑2020‑002638 33441387
    [Google Scholar]
  96. Lee J.W. Lee W.B. Kim W. Min B.I. Lee H. Cho S.H. Traditional herbal medicine for cancer pain: A systematic review and meta-analysis. Complement. Ther. Med. 2015 23 2 265 274 10.1016/j.ctim.2015.02.003 25847565
    [Google Scholar]
  97. Qureshi M. Zelinski E. Carlson L.E. Cancer and complementary therapies: Current trends in survivors’ interest and use. Integr. Cancer Ther. 2018 17 3 844 853 10.1177/1534735418762496 29629606
    [Google Scholar]
  98. Cunningham J.E. Kelechi T. Sterba K. Barthelemy N. Falkowski P. Chin S.H. Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Support. Care Cancer 2011 19 9 1473 1476 10.1007/s00520‑011‑1231‑8 21766161
    [Google Scholar]
  99. Jamsek M. Physiological effects of Swedish massage: A preliminary analysis of the fundamental techniques RMT 2013 1 27
    [Google Scholar]
  100. Laoudikou M.T. McCarthy P.W. Patients with cancer. Is there a role for chiropractic? J. Can. Chiropr. Assoc. 2020 64 1 32 42 32476666
    [Google Scholar]
  101. Haavik H. Murphy B. The role of spinal manipulation in addressing disordered sensorimotor integration and altered motor control. J. Electromyogr. Kinesiol. 2012 22 5 768 776 10.1016/j.jelekin.2012.02.012 22483612
    [Google Scholar]
  102. Cramer H. Lauche R. Klose P. Lange S. Langhorst J. Dobos G.J. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Libr. 2017 2017 1 CD010802 10.1002/14651858.CD010802.pub2 28045199
    [Google Scholar]
  103. Raghavendra R.M. Nagarathna R. Nagendra H.R. Gopinath K.S. Srinath B.S. Ravi B.D. Patil S. Ramesh B.S. Nalini R. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur. J. Cancer Care (Engl.) 2007 16 6 462 474 10.1111/j.1365‑2354.2006.00739.x 17944760
    [Google Scholar]
  104. McCracken L.M. Carson J.W. Eccleston C. Keefe F.J. Acceptance and change in the context of chronic pain. Pain 2004 109 1 4 7 10.1016/j.pain.2004.02.006 15082120
    [Google Scholar]
  105. Carson J.W. Carson K.M. Porter L.S. Keefe F.J. Seewaldt V.L. Yoga of awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial. Support. Care Cancer 2009 17 10 1301 1309 10.1007/s00520‑009‑0587‑5 19214594
    [Google Scholar]
  106. Vempati R.P. Telles S. Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychol. Rep. 2002 90 2 487 494 10.2466/pr0.2002.90.2.487 12061588
    [Google Scholar]
  107. Brown C.A. Jones A.K.P. Meditation experience predicts less negative appraisal of pain: Electrophysiological evidence for the involvement of anticipatory neural responses. Pain 2010 150 3 428 438 10.1016/j.pain.2010.04.017 20494517
    [Google Scholar]
  108. Zeidan F. Martucci K.T. Kraft R.A. Gordon N.S. McHaffie J.G. Coghill R.C. Brain mechanisms supporting the modulation of pain by mindfulness meditation. J. Neurosci. 2011 31 14 5540 5548 10.1523/JNEUROSCI.5791‑10.2011 21471390
    [Google Scholar]
  109. Tang Y.Y. Yang L. Leve L.D. Harold G.T. Improving executive function and its neurobiological mechanisms through a mindfulness‐based intervention: Advances within the field of developmental neuroscience. Child Dev. Perspect. 2012 6 4 361 366 10.1111/j.1750‑8606.2012.00250.x 25419230
    [Google Scholar]
  110. Zeidan F. Emerson N.M. Farris S.R. Ray J.N. Jung Y. McHaffie J.G. Coghill R.C. Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia. J. Neurosci. 2015 35 46 15307 15325 10.1523/JNEUROSCI.2542‑15.2015 26586819
    [Google Scholar]
  111. Elma Ö. Lebuf E. Marnef A.Q. Tümkaya Yilmaz S. Coppieters I. Clarys P. Nijs J. Malfliet A. Deliens T. Diet can exert both analgesic and pronociceptive effects in acute and chronic pain models: A systematic review of preclinical studies. Nutr. Neurosci. 2022 25 10 2195 2217 10.1080/1028415X.2021.1934956 34096825
    [Google Scholar]
  112. Fearon K.C. Voss A.C. Hustead D.S. Cancer Cachexia Study Group Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am. J. Clin. Nutr. 2006 83 6 1345 1350 10.1093/ajcn/83.6.1345 16762946
    [Google Scholar]
  113. Polak R. Dacey M.L. Phillips E.M. Time for food—including nutrition on physiatrists’ tables. PM R 2016 8 4 388 390 10.1016/j.pmrj.2015.09.026 27068557
    [Google Scholar]
  114. Brain K. Burrows T.L. Rollo M.E. Chai L.K. Clarke E.D. Hayes C. Hodson F.J. Collins C.E. A systematic review and meta‐analysis of nutrition interventions for chronic noncancer pain. J. Hum. Nutr. Diet. 2019 32 2 198 225 10.1111/jhn.12601 30294938
    [Google Scholar]
  115. Gomez-Pinilla F. Gomez A.G. The influence of dietary factors in central nervous system plasticity and injury recovery. PM R 2011 3 6S Suppl. 1 S111 S116 10.1016/j.pmrj.2011.03.001 21703566
    [Google Scholar]
  116. American Cancer Society Cannabis and Cancer American Cancer Society 2023
    [Google Scholar]
  117. Perucca E. Cannabinoids in the treatment of epilepsy: Hard evidence at last? J. Epilepsy Res. 2017 7 2 61 76 10.14581/jer.17012 29344464
    [Google Scholar]
  118. Urits I. Borchart M. Hasegawa M. Kochanski J. Orhurhu V. Viswanath O. An update of current cannabis-based pharmaceuticals in pain medicine. Pain Ther. 2019 8 1 41 51 10.1007/s40122‑019‑0114‑4 30721403
    [Google Scholar]
  119. Hill K.P. Palastro M.D. Johnson B. Ditre J.W. Cannabis and pain: A clinical review. Cannabis Cannabinoid Res. 2017 2 1 96 104 10.1089/can.2017.0017 28861509
    [Google Scholar]
  120. Zou S. Kumar U. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int. J. Mol. Sci. 2018 19 3 833 10.3390/ijms19030833 29533978
    [Google Scholar]
  121. Russo E.B. Burnett A. Hall B. Parker K.K. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem. Res. 2005 30 8 1037 1043 10.1007/s11064‑005‑6978‑1 16258853
    [Google Scholar]
  122. Bisogno T. Hanuš L. De Petrocellis L. Tchilibon S. Ponde D.E. Brandi I. Moriello A.S. Davis J.B. Mechoulam R. Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 2001 134 4 845 852 10.1038/sj.bjp.0704327 11606325
    [Google Scholar]
  123. Campos A.C. Moreira F.A. Gomes F.V. Del Bel E.A. Guimarães F.S. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012 367 1607 3364 3378 10.1098/rstb.2011.0389 23108553
    [Google Scholar]
  124. Yanes J.A. McKinnell Z.E. Reid M.A. Busler J.N. Michel J.S. Pangelinan M.M. Sutherland M.T. Younger J.W. Gonzalez R. Robinson J.L. Effects of cannabinoid administration for pain: A meta-analysis and meta-regression. Exp. Clin. Psychopharmacol. 2019 27 4 370 382 10.1037/pha0000281 31120281
    [Google Scholar]
  125. Smith L.A. Azariah F. Lavender V.T.C. Stoner N.S. Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst. Rev. 2015 2015 11 CD009464 10.1002/14651858.CD009464.pub2 26561338
    [Google Scholar]
  126. Häuser W. Welsch P. Radbruch L. Fisher E. Bell R.F. Moore R.A. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database Syst. Rev. 2023 6 6 CD014915 10.1002/14651858.CD014915.pub2 37283486
    [Google Scholar]
  127. Van Hal M. Dydyk A.M. Green M.S. Acupuncture. StatPearls. Treasure Island, FL StatPearls Publishing
    [Google Scholar]
  128. Fan A.Y. Miller D.W. Bolash B. Bauer M. McDonald J. Faggert S. He H. Li Y.M. Matecki A. Camardella L. Koppelman M.H. Stone J.A.M. Meade L. Pang J. Acupuncture’s Role in solving the opioid epidemic: Evidence, cost-effectiveness, and care availability for acupuncture as a primary, non-pharmacologic method for pain relief and management–White paper 2017. J. Integr. Med. 2017 15 6 411 425 10.1016/S2095‑4964(17)60378‑9 29103410
    [Google Scholar]
  129. Yang E.S. Li P.W. Nilius B. Li G. Ancient Chinese medicine and mechanistic evidence of acupuncture physiology. Pflugers Arch. 2011 462 5 645 653 10.1007/s00424‑011‑1017‑3 21870056
    [Google Scholar]
  130. Paley C.A. Johnson M.I. Tashani O.A. Bagnall A.M. Acupuncture for cancer pain in adults. Cochrane Database Syst. Rev. 2015 2015 10 CD007753 10.1002/14651858.CD007753.pub3 26468973
    [Google Scholar]
  131. Forsman A. K. Nordmyr J. Wahlbeck K. Psychosocial interventions for the promotion of mental health and the prevention of depression among older adults Health Promot Int. 2011 26 1 85 107 10.1093/heapro/dar074
    [Google Scholar]
  132. Kumar S. Morse M. Zemenides P. Jenkins R. Psychotherapies for psychological distress in the palliative care setting. Psychiatr. Ann. 2012 42 4 133 137 10.3928/00485713‑20120323‑05
    [Google Scholar]
  133. von Blanckenburg P. Leppin N. Psychological interventions in palliative care. Curr. Opin. Psychiatry 2018 31 5 389 395 10.1097/YCO.0000000000000441 29985177
    [Google Scholar]
  134. Faller H. Schuler M. Richard M. Heckl U. Weis J. Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. J. Clin. Oncol. 2013 31 6 782 793 10.1200/JCO.2011.40.8922 23319686
    [Google Scholar]
  135. Rehse B. Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: Meta analysis of 37 published controlled outcome studies. Patient Educ. Couns. 2003 50 2 179 186 10.1016/S0738‑3991(02)00149‑0 12781933
    [Google Scholar]
  136. Ruano A. García-Torres F. Gálvez-Lara M. Moriana J.A. Psychological and non-pharmacologic treatments for pain in cancer patients: A systematic review and meta-analysis. J. Pain Symptom Manage. 2022 63 5 e505 e520 10.1016/j.jpainsymman.2021.12.021 34952171
    [Google Scholar]
  137. Johannsen M. O’Connor M. O’Toole M.S. Jensen A.B. Højris I. Zachariae R. Efficacy of mindfulness-based cognitive therapy on late post-treatment pain in women treated for primary breast cancer: A randomized controlled trial. J. Clin. Oncol. 2016 34 28 3390 3399 10.1200/JCO.2015.65.0770 27325850
    [Google Scholar]
  138. Rodin G. Malfitano C. Rydall A. Schimmer A. Marmar C.M. Mah K. Lo C. Nissim R. Zimmermann C. Emotion And symptom-focused engagement (EASE): A randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia. Support. Care Cancer 2020 28 1 163 176 10.1007/s00520‑019‑04723‑2 31001692
    [Google Scholar]
  139. Warth M. Kessler J. Koehler F. Aguilar-Raab C. Bardenheuer H.J. Ditzen B. Brief psychosocial interventions improve quality of life of patients receiving palliative care: A systematic review and meta-analysis. Palliat. Med. 2019 33 3 332 345 10.1177/0269216318818011 30648926
    [Google Scholar]
  140. Beauchamp T.L. Childress J.F. Principles of biomedical ethics. Oxford Oxford Univ. Press 2001
    [Google Scholar]
  141. Cohen S.R. Mount B.M. Quality of life in terminal illness: Defining and measuring subjective well-being in the dying. J. Palliat. Care 1992 8 3 40 45 10.1177/082585979200800310 1279149
    [Google Scholar]
  142. Donnelly S. Walsh D. Quality of life assessment in advanced cancer. Palliat. Med. 1996 10 4 275 283 10.1177/026921639601000402 8931062
    [Google Scholar]
  143. Fowlie M. Berkeley J. Dingwall-Fordyce I. Quality of life in advanced cancer: The benefits of asking the patient. Palliat. Med. 1989 3 1 55 59 10.1177/026921638900300109
    [Google Scholar]
  144. Bruera E. Hui D. Dalal S. Torres-Vigil I. Trumble J. Roosth J. Krauter S. Strickland C. Unger K. Palmer J.L. Allo J. Frisbee-Hume S. Tarleton K. Parenteral hydration in patients with advanced cancer: A multicenter, double-blind, placebo-controlled randomized trial. J. Clin. Oncol. 2013 31 1 111 118 10.1200/JCO.2012.44.6518 23169523
    [Google Scholar]
  145. Tait R.C. Vulnerability in clinical research with patients in pain: A risk analysis. J. Law Med. Ethics 2009 37 1 59 72 10.1111/j.1748‑720X.2009.00351.x 19245603
    [Google Scholar]
  146. Johnston S.D. Tham T.C.K. Mason M. Death after PEG: Results of the national confidential enquiry into patient outcome and death. Gastrointest. Endosc. 2008 68 2 223 227 10.1016/j.gie.2007.10.019 18329030
    [Google Scholar]
  147. Akdeniz M. Yardımcı B. Kavukcu E. Ethical considerations at the end-of-life care. SAGE Open Med. 2021 9 20503121211000918 10.1177/20503121211000918 33786182
    [Google Scholar]
  148. Johnson M. Collett B. Castro-Lopes J.M. Johnson M. The challenges of pain management in primary care: A pan-European survey. J. Pain Res. 2013 6 May 393 401 10.2147/JPR.S41883 23723719
    [Google Scholar]
  149. Carvalho A. S. Martins Pereira S. Jácomo A. Magalhães S. Araújo J. Hernández-Marrero P. Costa Gomes C. Schatman M.E. Ethical decision making in pain management: A conceptual framework 2018 10.2147/JPR.S162926
    [Google Scholar]
  150. Eichelberger T. Shadiack A. “Life expectancy with Hospice Care. Am Fam Physician 2018 97 5
    [Google Scholar]
  151. Burton A.W. Hamid B. Current challenges in cancer pain management: Does the WHO ladder approach still have relevance? Expert Rev. Anticancer Ther. 2007 7 11 1501 1502 10.1586/14737140.7.11.1501 18020918
    [Google Scholar]
  152. Sazuka S. Koitabashi T. Tapentadol is effective in the management of moderate-to-severe cancer-related pain in opioid-naïve and opioid-tolerant patients: A retrospective study. J. Anesth. 2020 34 6 834 840 10.1007/s00540‑020‑02821‑8 32648017
    [Google Scholar]
  153. Zheng Q. Fang D. Cai J. Wan Y. Han J.-S. Xing G.-G. Enhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain Mol Pain 2012 8 1744 8069 10.1186/1744‑8069‑8‑24
    [Google Scholar]
  154. NeuroMetrix Quell® Demonstrates encouraging clinical trial results in chemotherapy induced peripheral neuropathy (CIPN). investor.neurometrix.com/news-releases/news-release-details/quellr-demonstrates-encouraging-clinical-trial-results
  155. Gewandter J.S. Culakova E. Davis J.N. Gada U. Guido J.J. Burnette B.L. Bearden J.D. O’Rourke M.A. Mustian K.M. Morrow G.R. Sluka K.A. Mohile N. Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT). J. Clin. Oncol. 2023 41 16_suppl _Suppl. e24134 e24134 10.1200/JCO.2023.41.16_suppl.e24134
    [Google Scholar]
  156. CORDIS AI tools could offer cancer patients more personalised aftercare. cordis.europa.eu/article/id/448150-ai-tools-could-offer-cancer-patients-more-personalised-aftercare
    [Google Scholar]
  157. Alshammary S.A. Punalvasal Duraisamy B. Salem L. Altamimi A. Integration of palliative care into primary health care: Model of care experience. Cureus 2020 12 6 e8866 10.7759/cureus.8866 32754404
    [Google Scholar]
  158. Viderman D. Tapinova K. Aubakirova M. Abdildin Y.G. The prevalence of pain in chronic diseases: An umbrella review of systematic reviews. J. Clin. Med. 2023 12 23 7302 10.3390/jcm12237302 38068354
    [Google Scholar]
  159. Viderman D. Tapinova K. Dossov M. Seitenov S. Abdildin Y.G. Virtual reality for pain management: An umbrella review. Front. Med. (Lausanne) 2023 10 1203670 10.3389/fmed.2023.1203670 37521355
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673333227250106085952
Loading
Advanced Pain Management in Patients with Terminal Cancer
Bentham Science Publishers ; https://doi.org/10.2174/0109298673333227250106085952
/content/journals/cmc/10.2174/0109298673333227250106085952
/content/journals/cmc/10.2174/0109298673333227250106085952
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: cancer-related pain ; opioids ; Pain management ; terminal cancer ; interventional therapy ; non-pharmacological interventions

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test